EBERHARD BLIND
Impact in
- Nephrology top 2%
- Parathyroid Disorders and Treatments
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
- Nephrology 15
- Parathyroid Disorders and Treatments 15
- Oncology 29
- Bone health and treatments 27
- Co-authors
- Kristina Dunder (4 shared papers)Curtis J. Rosebraugh (2 shared papers)B. Timothy Hummer (2 shared papers)Tom BOURCIER (1 shared paper)Amy Egan (1 shared paper)Friedhelm Raue (17 shared papers)H. Schmidt‐Gayk (7 shared papers)Robert A. Nissenson (3 shared papers)
- Journals
- Clinical Chemistry (4 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)Bone (3 papers)Recent results in cancer research (2 papers)European Heart Journal (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
EBERHARD BLIND
50 papers receiving 1.3k citations
EBERHARD BLIND's Hit Papers
Peers
Comparison fields: 5 of 81
- Nephrology 280
- Endocrinology, Diabetes and Metabolism 477
- Oncology 400
- Orthopedics and Sports Medicine 111
- Molecular Biology 475
Countries citing papers authored by EBERHARD BLIND
This map shows the geographic impact of EBERHARD BLIND's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EBERHARD BLIND with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EBERHARD BLIND more than expected).
Fields of papers citing papers by EBERHARD BLIND
This network shows the impact of papers produced by EBERHARD BLIND. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EBERHARD BLIND. The network helps show where EBERHARD BLIND may publish in the future.
Co-authors
The 25 scholars most cited alongside EBERHARD BLIND, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment Hit paper breakdown → | 2014 | 411 |
| 2 | 2006 | 116 | |
| 3 | 1988 | 100 | |
| 4 | 1994 | 63 | |
| 5 | 1993 | 60 | |
| 6 | 1995 | 55 | |
| 7 | 2010 | 48 | |
| 8 | 1996 | 47 | |
| 9 | 1987 | 43 | |
| 10 | 2001 | 41 | |
| 11 | 1992 | 39 | |
| 12 | 1992 | 35 | |
| 13 | 1992 | 30 | |
| 14 | 1990 | 28 | |
| 15 | 2018 | 23 | |
| 16 | 1992 | 15 | |
| 17 | 1992 | 14 | |
| 18 | 2002 | 14 | |
| 19 | 1993 | 13 | |
| 20 | 2007 | 13 |
About EBERHARD BLIND
EBERHARD BLIND is a scholar working on Nephrology, Oncology, Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine and Molecular Biology, having authored 52 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bone health and treatments (27 papers), Parathyroid Disorders and Treatments (15 papers), Metabolism, Diabetes, and Cancer (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Genetic Syndromes and Imprinting (6 papers), Neuropeptides and Animal Physiology (6 papers), Thyroid Disorders and Treatments (4 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Nephrology (280 citations), Endocrinology, Diabetes and Metabolism (477 citations), Oncology (400 citations), Orthopedics and Sports Medicine (111 citations) and Molecular Biology (475 citations). EBERHARD BLIND has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Kristina Dunder, Curtis J. Rosebraugh, B. Timothy Hummer, Tom BOURCIER, Amy Egan, Friedhelm Raue, H. Schmidt‐Gayk, Robert A. Nissenson, R. Ziegler and Tom Bambino. Their work appears in journals such as Clinical Chemistry, The Journal of Clinical Endocrinology & Metabolism, Bone, Recent results in cancer research and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.